Sylvio is the Scientific programs coordinator at Adebiotech, the Paris-based transdisciplinary biotechnology independent think tank since October 2018. Starting with an academic background in cellular immunology, he gained confirmed >20 years experience in Bioproduction and Purification of therapeutic proteins (and gene therapy vectors). He acquired strong technical and strategic business development experience in various scientific domains (chromatography, cell culture, molecular biology, high-end instrumentation, proteomics, analytical services) through management positions at PALL Life Sciences, Ciphergen Biosystems, Life Technologies, Merck/VWR, BioSepra/Sepracor Inc

Before joining Adebiotech he acted as a strategy consultant for international biotech organizations . Sylvio is a multicultural person and has been a frequent speaker and moderator at various academic and industrial BioProcessing related conferences worldwide.

Denis Chéreau est le Directeur Général d’IMPROVE. Il a participé au lancement de LYVEN startup dans le monde de la production d’enzymes et de métabolites par fermentation en milieu solide. Il a ensuite passé près de 15 ans dans le secteur de l’amidonnerie / glucoserie sur des postes de directions techniques ou de directions d’usines en France et aux USA. Depuis 8 ans au sein d’IMPROVE il a contribuer à développer une offre de prestation de service en R&D sur la thématique des protéines alternatives pour plus de 400 sociétés dans le monde.

Sune is a biotechnologist with more than 10 years of experience with research and innovation in academia and industry leading cross-functional and cross-sectorial project teams spanning basic science, early-stage R&D and product development. His scientific areas of expertise include enzyme mechanisms, protein engineering, high throughput screening and quantitative microscopy. Sune is particularly interested in the problem of climate change mitigation and is engaged in product development, project scoping and technology scouting activities in this area.

Prior to joining Novozymes, Sune was a Postdoc at UC Berkeley where he studied signaling proteins involved in immune cell activation and cancer. Sune holds a PhD in chemistry from the University of Copenhagen and a master’s degree in nanoscience from the University of Copenhagen.

Philippe holds a PhD in Molecular Biology from the Université Libre de Bruxelles (ULB) obtained in 1993 and a Master in Management de l’Innovation from HEC Saint Louis (Brussels, Belgium) obtained in 1995.

In 1995-1996 Philippe did a post-doctoral research at the University of Edinburgh (UK).  During this research he discovered using mouse model the function of the alpha-fetoprotein the major embryonic plasma protein in mammalian development.  

During his academic research career he was involved has an inventor in the development of a portfolio of genetic selection patented technologies. 

One of these technologies belonging to ULB was licensed to Life technologies and is on the market since 1995 it is today a standard in DNA assembly method: Gateway technology, TOPO cloning. Other technologies were licensed to Sanofi-Pasteur, GSK and Merck to improve biopharmaceutical production.

Since 2013 Philippe is the founder and Chief Scientific Officer of Syngulon a startup focusing on genetic innovations to improve the biocontrol of microbial population using bacteriocins (antimicrobial peptides). Philippe has established several partnerships for the company with academics and industries. 

Danielle Lando est titulaire d’un doctorat d’état obtenu à l’Institut Pasteur de Paris pour la recherche en virologie. Elle a effectué sa carrière dans l’industrie pharmaceutique où elle a exercé des fonctions de chercheur en pharmacologie cellulaire et moléculaire avant de prendre la responsabilité des biotechnologies au sein de Roussel Uclaf devenu Sanofi. Elle a œuvré pour des rapprochements entre son entreprise et le secteur académique en soutenant des projets collaboratifs. Elle a été membre nommé au Comité National du CNRS de 1995 à 2000.

Depuis 2001, elle exerce des activités scientifiques bénévoles au sein d’Adebiotech, association dont elle est actuellement Vice-Présidente.

Juliette i is Scientific Communication Manager at Seqens. After a PhD in organic chemistry at university of Caen, she pursued a career in Industry at Zeneca Life Sciences (in UK) as R&D Project Leader (in 1999), then as R&D group leader in a Fine Chemical company: Zach System in France (Angers). In 2006, she became Head of Biocatalysis for pharmaceutical services at PCAS site in Aramon (France). In 2009, she was appointed R&D Manager focusing on process scale-up and technology development. In 2012, she hold the position of General Manager at Protéus.

Since 2022, she focuses on leveraging R&D partnerships and scientific communication.

After an agricultural engineer School in France (Lasalle Beauvais), Alexis RANNOU joined ARD for activities in R&D to extract non digestible sugar for surfactant application (1991-1995). He was after in charge of ARD’s pilot plant (1995-1997).

In 1997 he joined the Soliance company (daughter company of ARD) as technical director.

In 2000 he was named as Deputy General Manager in charge of the industrial production.

In 2007 he was in charge of the innovation team and several global accounts.

In 2014 he joined Givaudan as Operations Director & site manager

Since 2018, he held the position of Head of Operations Strategy in charge of tolling & process development for Givaudan Active Beauty

Magali Remaud Simeon is Professor at the National Institute of Applied Sciences of Toulouse and is head of the Catalysis and Enzyme Molecular Engineering group of the “Laboratoire d’Ingénierie des Système Biologiques and Procédé (LISBP). She received her PhD in Biochemistry from the University of Toulouse and was Post-Doc at the University of Pennsylvania. She has co-authored more than 150 papers and is co-inventor of 22 patents. Her research activities focus on Enzyme Engineering for white biotechnology, green chemistry, health, food/feed industries and synthetic biology. They cover enzyme structure/activity relationship studies, kinetic resolution, evolution combining both rational and combinatorial approaches, and applications to the synthesis of glycans, glycoconjugates and various synthons of interest. Her work is currently focused on the search and generation of enzymes displaying new specifi cities and improved catalytic properties. Her objective is to open new trajectories for biomass transformation. To this end, she specifi cally targets the integration of tailored enzymes in chemo-enzymatic cascades, new metabolic pathways or enzyme-based processes.

With a dual expertise in Biochemistry and Marketing, Jacky VANDEPUTTE began his career in the field of quality and promotion of agri-food industries, first within a dairy ingredient trading company and then at UNIJUS, an association for fruit juice. He then joined the french competitiveness cluster Bioeconomy For Change, where he spent 17 years of his career as innovation director and established key services: the TREMPLIN monitoring platform, led the
thematic working groups (plant chemistry and industrial biotechnology), launched the plant based innovation kit, coordinated the regional biobased innovation program, the action « introduce biomass into your company, » and the collective actions « vegereach »: finding plant-based alternatives to hazardous substances and « IARACV »: « Demonstrating the environmental and socio-economic benefits of bioproducts. » As a coordinator for R&D projects, particularly in the field of plant chemistry and industrial biotechnology (Biomolecules), he is sought after for his expertise by numerous organizations to support project leaders and assess their applications, including TWB, GENOPOLE, and the Agrio label. With a total of over 360 R&D&I projects financed, totaling more than 2 billion euros, resulting in new bioproducts (biolubricants, bio-sourced coatings, plant-based adhesives, etc.) and new factories ; he has organized and led more than a hundred events and working groups on the topics of bioeconomy, plant chemistry, and industrial biotechnology. His support has extended to numerous chemical groups and SMEs in evaluating their project portfolios and defining their strategies, as well as participating in the development of various bioeconomy platforms…